PUNE, India, February 22, 2016 /PRNewswire/ --

Global hemostats market size is projected to reach USD 2.76 billion by 2020, at a CAGR of 6.2% during from 2015 to 2020 with increasing number of surgery procedures and insurance providers bearing the high cost of these medical devices like hemostats products, being the major factors influencing the growth of this market.

Complete report on global hemostats market spread across 159 pages, profiling 11 companies and supported with 199 tables and 90 figures is now available at http://www.reportsnreports.com/reports/482939-hemostats-market-by-product-type-thrombin-oxidised-regenerated-cellulose-combination-gelatin-collagen-and-geography-americas-europe-apac-mea-global-forecast-to-2020.html .

The administration and monitoring of hemostats during surgical procedures is a complex task for clinicians, as it depends upon the blood flow from the particular area of surgery. The usages of hemostats have no adverse effects and are an important procedure to prevent blood loss in patients, especially among the aging population. The market for hemostats is rapidly increasing with technological advancements and increasing number of surgeries. Also, hospitals and healthcare facilities are gradually increasing, supported by government which in turn is driving the growth of the hemostats market.

Hemostats are one of the sub-markets of wound closure devices. Over the years, these products have been used during surgeries to stop bleeding within a short span of time. These products are biodegradable, absorbable, and cost-effective. They have tenure of maximum 2 years with no adverse effects.

Based on product type, this market is segmented into thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats, thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats.

Based on geography, the global hemostats market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures.  However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries is propelling the growth of this market.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.). Order a copy of Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020 research report at http://www.reportsnreports.com/purchase.aspx?name=482939 .

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis, market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities for the global Hemostats market.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

On a related note, another research on HPV Testing & Pap Test Market Global Forecast to 2020 says, the HPV testing and Pap test Market is estimated to grow at a CAGR of 6.6% to reach USD 4,523.1 Million by 2020. Increasing awareness of cervical cancer screening programs, and government initiative and funding are the Major Drivers of the HPV testing and Pap test Market. Companies like Abbott Laboratories, Qiagen N.V., Hologic Inc., Roche Diagnostics, Quest Diagnostics, Becton, Dickinson and Company have been profiled in this 124 pages research report available at  http://www.reportsnreports.com/reports/479620-hpv-testing-pap-test-market-by-test-type-hpv-testing-follow-up-co-testing-primary-by-application-pap-test-cervical-cancer-vaginal-cancer-by-end-user-laboratories-hospitals-physicians-offices-clinics-global-forecast-to-2020.html .

Explore more reports on medical devices market at http://www.reportsnreports.com/market-research/medical-devices/ .

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Connect With Us on:  

Facebook: https://www.facebook.com/ReportsnReports/

LinkedIn: https://www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports  

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

RSS/Feeds:  http://www.reportsnreports.com/feed/l-latestreports.xml  

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

SOURCE ReportsnReports